As part of its OncView™ video series, CancerNetwork® spoke with Sameh Gaballa, MD, of the Moffit Cancer Center, about current and future treatment options, and considerations for patients with relapsed/refractory follicular lymphoma.

 

In the video series, Gaballa discussed the following:

·      Treatment Options in Relapsed/Refractory Follicular Lymphoma

·      Considerations for Treatment Selection in R/R FL

·      Third-Line Therapy in Follicular Lymphoma

·      Tazemetostat for Relapsed/Refractory Follicular Lymphoma

·      R/R FL: The Role of PI3K Inhibitors

·      Unmet Needs and Looking Ahead in Follicular Lymphoma

 

To watch more videos in CancerNetwork®’s OncView™ series, visit cancernetwork.com/oncview.